TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-Founder Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Trading Report (Form 4)


Atlassian Co-Founder and CEO Michael Cannon-Brookes sold 7,665 Class A Common Stock shares on August 26, 2025, as part of a pre-arranged 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, Atlassian's Co-Founder, CEO, Director, and 10% Owner, sold a total of 7,665 shares of Class A Common Stock.
  • The sales occurred on August 26, 2025, and were executed pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
  • The shares were sold at weighted-average prices ranging from $164.5556 to $169.635 per share.
  • Following these transactions, Cannon-Brookes indirectly beneficially owns 183,960 shares through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

Sentiment

Score: 5

Explanation: The sale of shares by a key insider is generally a negative signal. However, the execution under a pre-arranged 10b5-1 trading plan mitigates the negative sentiment, as it indicates a planned liquidity event rather than a reaction to new, adverse information.

Negatives

  • A key insider, who is a Co-Founder, CEO, and Director, sold a significant number of shares.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • Shares are indirectly held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, which is a related entity to the reporting person.

Stakeholder Impact

  • Shareholders may interpret the insider sale as a negative signal, although the 10b5-1 plan mitigates concerns about immediate adverse company-specific news.

Key Dates

DateDescription
2025-02-20Rule 10b5-1 trading plan adopted by Michael Cannon-Brookes.
2025-08-26Date of Class A Common Stock sales transactions.
2025-08-27Date of Form 4 filing.

Recommendation

hold

While an insider sale by a Co-Founder and CEO could be a cause for concern, the transaction was executed under a pre-arranged 10b5-1 trading plan. This suggests a planned liquidity event rather than a reaction to new, negative company developments. Investors should monitor future filings and company performance, but this specific transaction alone does not warrant a 'sell' recommendation, nor does it provide new positive information for a 'buy'.

Keywords

Atlassian, TEAM, Michael Cannon-Brookes, Insider Sale, Form 4, 10b5-1 Plan, Equity Transaction, CEO, Director, 10% Owner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.